Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Nov 28:10:2329048X231216432.
doi: 10.1177/2329048X231216432. eCollection 2023 Jan-Dec.

A Novel Homozygous Variant in the CHRNE Gene in 2 Siblings with Congenital Myasthenic Syndrome

Affiliations
Case Reports

A Novel Homozygous Variant in the CHRNE Gene in 2 Siblings with Congenital Myasthenic Syndrome

Cassie Chan et al. Child Neurol Open. .

Abstract

Cholinergic receptor nicotinic epsilon (CHRNE) subunit mutations cause postsynaptic type of congenital myasthenic syndrome either as a primary acetylcholine-receptor deficiency or abnormal channel kinetics in the receptor. We report a novel homozygous variant (c.322C > T, p.Pro108Ser) in the epsilon subunit causing primary acetylcholine-receptor deficiency in two siblings. Two siblings presented with fatigable weakness. Both siblings had whole exome sequencing showing a homozygous variant (c.322C > T, p.Pro108Ser) of unknown significance in the epsilon subunit. Electromyography/nerve conduction study with repetitive nerve stimulation on one sibling showed a defect in neuromuscular junction transmission. Pseudoephedrine and fluoxetine for suspected slow-channel congenital myasthenic syndrome yielded no improvement. A trial of pyridostigmine led to clinical improvement. Given the clinical presentation, consanguinity, homozygous genetic variant, and response to pyridostigmine, we rationalize the homozygous variant (c.322C > T, p.Pro108Ser) in cholinergic receptor nicotinic epsilon subunit causes the primary acetylcholine-receptor deficiency congenital myasthenic syndrome.

Keywords: CHRNE; CMS; congenital myasthenic syndrome; neuromuscular; pediatric.

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Engel AG, Shen XM, Selcen D, Sine SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol. 2015;14(4):420–434. doi:10.1016/S1474-4422(14)70201-7 - DOI - PMC - PubMed
    1. Rodríguez Cruz PM, Palace J, Beeson D. The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes. Int J Mol Sci. 2018;19(6):1677. doi:10.3390/ijms19061677 - DOI - PMC - PubMed
    1. Rodríguez Cruz PM, Palace J, Beeson D. Congenital myasthenic syndromes and the neuromuscular junction. Curr Opin Neurol. 2014;27(5):566–575. doi:10.1097/WCO.0000000000000134 - DOI - PubMed
    1. Faber CG, Molenaar PC, Vles JSH, et al. AChr deficiency due to epsilon-subunit mutations: two common mutations in The Netherlands. J Neurol. 2009;256(10):1719–1723. doi:10.1007/s00415-009-5190-7 - DOI - PMC - PubMed
    1. Finsterer J. Congenital myasthenic syndromes. Orphanet J Rare Dis. 2019;14(1):57. doi:10.1186/s13023-019-1025-5 - DOI - PMC - PubMed

Publication types

LinkOut - more resources